Velpaclear Tablet 28 is used to manage chronic hepatitis C virus (HCV) infection in adults and children aged three years and above. It is a combination of direct-acting antivirals: sofosbuvir, a nucleotide polymerase inhibitor, and velpatasvir, an NS5A inhibitor.
This medicine is effective across multiple HCV genotypes, making it suitable for patients with or without compensated cirrhosis. It serves as a valuable option for both treatment-naïve patients and those who have previously tried other HCV therapies without success. In certain clinical situations, your doctor might recommend using this medicine alongside other treatments, particularly if you have decompensated cirrhosis.
This medicine should be taken as directed by your doctor. Before beginning treatment, inform your doctor about any pre-existing conditions you have and about any other medicines you are currently taking. If you experience any side effects during treatment, notify your doctor promptly. Continue taking the medicine for the full duration prescribed by your doctor for optimal results.